Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Fas C- Terminal Tripeptide;189109-90-8;Fas C-Terminal Tripeptide;(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoic acid;Ac-Ser-Leu-Val-OH;CHEMBL110417;DA-63378;HY-103323;CS-0027635;(S)-2-((S)-2-((S)-2-acetamido-3-hydroxypropanamido)-4-methylpentanamido)-3-methylbutanoic acid; |
M.F/Formula | C16H29N3O6 |
M.W/Mr. | 359.42 |
Sequence | One Letter Code:SLV Three Letter Code:Ac-Ser-Leu-Val-OH |
InChI | InChI=1S/C16H29N3O6/c1-8(2)6-11(14(22)19-13(9(3)4)16(24)25)18-15(23)12(7-20)17-10(5)21/h8-9,11-13,20H,6-7H2,1-5H3,(H,17,21)(H,18,23)(H,19,22)(H,24,25)/t11-,12-,13-/m0/s1 |
InChI Key | ORIIRLCDJGETQD-AVGNSLFASA-N |
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
Required fields are marked with *
×Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.